Loading, please wait....jpg)
.jpg)
The Premier October 23, 2025 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Stopping the Bleed in 2025, an Anticoagulation Reversal and Hemostasis Update
Speaker: Michael Gulseth, PharmD, BCPS, FMSHP, FASHP, Anticoagulation Stewardship Director, PGY-2 Thrombosis and Hemostasis Management Residency Program Director, Sanford USD Medical Center, Sioux Falls, SD
ACPE Universal Activity Number: 0122-0000-25-030-L01-P [0.1 CEU] [1 Contact Hr.]
Date: Oct 23, 2025 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Oct 23, 2025 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Objectives
- Classify the different available prothrombin complex concentrate products
- Review the results of the two phase three clinical trials for the more recently approved 4 factor prothrombin complex concentrate (4F-PCC) known in the United States as Balfaxar
- Explain recent literature on the efficacy of PCCs and andexanet alfa in promotion of hemostasis in patients bleeding on factor Xa inhibitor therapy
- Describe the current society guidelines on the interchangeability of 4F-PCC products
Speaker(s)/Author(s)
|
Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP
|